Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

393.59 +0.88 (+0.22%)
Streaming Delayed Price Updated: 1:25 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
How Do Investors Really Feel About Stryker?
Via Benzinga
Stryker receives FDA clearance for Incompass Total Ankle System
From Stryker
Via Business Wire
Stryker (SYK): Buy, Sell, or Hold Post Q1 Earnings?
Since December 2024, Stryker has been in a holding pattern, posting a small return of 1.1% while floating around $376.76. 
Via StockStory
Topics Supply Chain
2 Safe-and-Steady Stocks to Research Further and 1 to Approach with Caution
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
How Do Investors Really Feel About Stryker?
Via Benzinga
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Steady growth and dividend increases over decades can make investors remarkably wealthy. 
Via The Motley Fool
Topics Economy
5 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stryker Receives FDA Clearance For OptaBlate System Aimed At Low Back Pain Relief: Retail’s Yet To React
OptaBlate BVNA is used in a targeted minimally invasive procedure to relieve vertebrogenic low back pain. 
Via Stocktwits
Topics World Trade
Recent Filing Shows That Rep. Thomas Kean Bought Over $9K Worth of Amazon.com Stock
Via Benzinga
SYK Q1 Earnings Call: Stryker Delivers Revenue Beat, Cites International Growth and Tariff Headwinds
Medical technology company Stryker (NYSE:SYK) announced better-than-expected revenue in Q1 CY2025, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 per share was 4% above... 
Via StockStory
Topics Economy
2 Large-Cap Stocks on Our Watchlist and 1 to Think Twice About
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
3 Healthcare Stocks to Keep an Eye On
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional Stocks
These longtime Fundsmith holdings are still great buys today. 
Via The Motley Fool
Topics Artificial Intelligence
Stryker declares an $0.84 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
Stryker, Lockheed Martin, Rockwell Automation And More On CNBC's 'Final Trades'
Via Benzinga
Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers. 
Via StockStory
Demystifying Stryker: Insights From 5 Analyst Reviews
Via Benzinga
2 S&P 500 Stocks Worth Investigating and 1 to Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Stryker’s (NYSE:SYK) Q1: Beats On Revenue
Medical technology company Stryker (NYSE:SYK) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 per... 
Via StockStory
Here's How Much $1000 Invested In Stryker 10 Years Ago Would Be Worth Today
Via Benzinga
Stryker reports first quarter 2025 operating results
From Stryker Corporation
Via GlobeNewswire
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year? 
Via Investor's Business Daily
Topics Animal Testing Economy Government
Stryker (SYK) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Stryker (NYSE:SYK) will be reporting earnings tomorrow after market close. Here’s what investors should know. 
Via StockStory
Topics Economy World Trade
Stryker to participate in the Bank of America Securities 2025 Global Healthcare Conference
From Stryker Corporation
Via GlobeNewswire
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.